PCSA Processa Pharmaceuticals, Inc.
$2.08▲ +10.93%
Healthcare
Other
After hours
$1.98▼ -4.90%
Sep 11, 7:30 PM ET
Volume 39.0K
Avg Volume (10D) 25.3K
Key Metrics & Fundamentals
Market Cap
$5.81M
P/E Ratio
3.2
Div Yield
–%
52W Range
1.67 - 14.25
% vs 50 MA
-6.71%
% vs 200 MA
-28.18%
RSI-14
47.5
MACD Histogram
-0.0100
Beta (1Y vs SPY)
1.49
Free Cash Flow
-$2.50M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$1.41M
COGS
–
Operating Exp
$2.34M
Operating Income
-$2.34M
EBIT
-$2.34M
Pretax Income
-$3.27M
Net Income
-$3.27M
EPS (Diluted)
-1.19
Price & Volume History
Loading chart…
Recent News
Processa Pharmaceuticals to Participate in Upcoming Investor Conferences
GlobeNewswire · Sep 1, 2026 11:00 AM
Processa Pharmaceuticals Acquires Vidya Therapeutics and Secures $200 Million Financing to Advance BTK Inhibitor Pipeline
InvestorsHub · Jul 29, 2026 2:33 PM
PROCESSA PHARMACEUTICALS, INC. ANNOUNCES ACQUISITION OF VIDYA THERAPEUTICS, INC. AND APPROXIMATELY $200 MILLION CONCURRENT PRIVATE PLACEMENT TO ADVANCE BTK INHIBITOR, VT-7208, IN MULTIPLE DISEASE AREAS
GlobeNewswire · Jul 29, 2026 11:30 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See PCSA's money flow as a full page
Social Sentiment
No Reddit posts found for PCSA.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.